Form 4: Incyte Director Julian Baker Receives Stock for Fees

Julian C. Baker, a director and 10% owner of Incyte Corp, received 328 shares of common stock in lieu of quarterly director retainer fees, as reported in a recent SEC Form 4 filing.

Summary

• Julian C. Baker, a director and 10% owner of Incyte Corp, acquired 328 shares of common stock on December 31, 2025.
• These shares were issued under Incyte's Amended and Restated 2010 Stock Incentive Plan, in lieu of quarterly director retainer fees totaling $33,000.
• The acquired shares are fully vested upon issuance.
• The filing details complex indirect beneficial ownership structures involving Baker Bros. Advisors LP, 667, L.P., Baker Brothers Life Sciences LP, and their general partners.
• Julian C. Baker and Felix J. Baker, managing members of Baker Bros. Advisors (GP) LLC, disclaim beneficial ownership of securities held by the Funds except to the extent of their pecuniary interest.
• After this transaction, indirect beneficial ownership attributed to the reporting entities includes 2,817,618 shares and 28,188,297 shares of common stock.
• Julian C. Baker directly holds 278,773 shares, and Felix J. Baker directly holds 281,190 shares.
• Julian C. Baker and Felix J. Baker also have an indirect pecuniary interest in 33,410 shares held by FBB Associates.

Sentiment

Score: 5

Explanation: The filing is a neutral, factual report of an insider transaction and beneficial ownership, with no inherently positive or negative implications for the company's operational or financial performance.

Positives

• Julian C. Baker, a director, is compensated with company stock, which aligns his interests with those of shareholders.
• The shares received are fully vested, indicating immediate ownership and no future vesting conditions.

Future Outlook

The filing is a transaction report and does not contain any forward-looking statements or guidance regarding Incyte Corporation's future performance or strategic direction.

Management Comments

• Julian C. Baker, a managing member of Baker Bros. Advisors (GP) LLC, the sole general partner of Baker Bros. Advisors LP, is a director of Incyte Corporation (the 'Issuer').
• By virtue of their representation on the board of directors of the Issuer, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the reporting persons other than Julian C. Baker are deemed directors by deputization of the Issuer.
• Julian C. Baker, Felix J. Baker, the Adviser GP and the Adviser disclaim beneficial ownership of the securities held directly by the Funds or for the benefit of the Funds except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of Julian C. Baker, Felix J. Baker, the Adviser GP or the Adviser is a beneficial owner of such securities for purposes of Section 16 or any other purpose.

Industry Context

This Form 4 filing details an insider transaction related to director compensation, which is a routine disclosure for publicly traded companies. It does not provide broader industry context or competitive analysis.

Corporate Governance

Related Party Transactions

• Julian C. Baker, a director of Incyte, received stock compensation. He is also a managing member of Baker Bros. Advisors (GP) LLC, which is the general partner of Baker Bros. Advisors LP, the investment adviser to 667, L.P. and Baker Brothers Life Sciences, L.P., both 10% owners of Incyte. This constitutes a related party transaction where a director and affiliated entities are involved in the company's equity.

Stakeholder Impact

• Shareholders: The issuance of shares for director compensation results in minor dilution but aligns director incentives with shareholder value. The detailed beneficial ownership disclosures provide transparency regarding significant institutional holders.

Key Dates

Keywords

Incyte Corp, INCY, SEC Form 4, Insider Transaction, Stock Compensation, Director Compensation, Beneficial Ownership, Baker Bros. Advisors, Julian C. Baker, Felix J. Baker, Equity Grant